Kathleen M. Hillgren

Author

Eli Lilly (United States)

Also Known As

K M Hillgren, K. M. HILLGREN, Kathleen Hillgren, Kathleen M Hillgren, Kathleen M. Hillgren

Publications

5.2K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Boehringer Ingelheim (Germany)Millennium Engineering and Integration (United States)University of California, San Francisco Bristol-Myers Squibb (United States)

About

Kathleen M. Hillgren is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	283
2	Biochemistry	2	2	43
3	Business	1	1	77
4	Engineering	1	1	14
5	Genetic Medicine	1	1	163

Kathleen M. Hillgren

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms Kathleen M. Giacomini, Praveen Balimane, Sangeun Cho, Clinical Pharmacology & Therapeutics Molecular PharmacologyAllelic VariantMembrane TransportersGenetic PolymorphismsMedicine	2013	163
Targeted Disruption of Peptide Transporter<i>Pept1</i>Gene in Mice Significantly Reduces Dipeptide Absorption in Intestine Yongun Hu, David E. Smith, Ke Ma, Molecular Pharmaceutics	2008	123
Characterization of the Unstirred Water Layer in Caco-2 Cell Monolayers Using a Novel Diffusion Apparatus Ismael J. Hidalgo, Kathleen M. Hillgren, George M. Grass, Pharmaceutical Research	1991	120
Highlights from the International Transporter Consortium Second Workshop M J Zamek-Gliszczynski, Keith Hoffmaster, Donald Tweedie, Clinical Pharmacology & Therapeutics PharmacotherapyTransport SectorTranslational MedicineItc Decision TreesSystems Engineering	2012	77
Enhanced Transepithelial Transport of Peptides by Conjugation to Cholic Acid Peter W. Swaan, Kathleen M. Hillgren, Francis C. Szoka, Bioconjugate Chemistry	1997	71
Genetic Polymorphisms in Human Proton-Dependent Dipeptide Transporter PEPT1: Implications for the Functional Role of Pro586 Eric Y. Zhang, Dong‐Jing Fu, Y. Anne Pak, Journal of Pharmacology and Experimental Therapeutics	2004	63
Prediction of Transporter‐Mediated Drug‐Drug Interactions for Baricitinib Maria M. Posada, Ellen A. Cannady, Christopher D. Payne, Clinical and Translational Science	2017	59
Prediction of Renal Transporter Mediated Drug-Drug Interactions for Pemetrexed Using Physiologically Based Pharmacokinetic Modeling Maria M. Posada, James A. Bacon, Karen Schneck, Drug Metabolism and Disposition	2014	57
Advances in blood–brain barrier modeling in microphysiological systems highlight critical differences in opioid transport due to cortisol exposure Jacquelyn A. Brown, Shannon L. Faley, Yajuan Shi, Fluids and Barriers of the CNS	2020	47
Chimeric TK-NOG Mice: A Predictive Model for Cholestatic Human Liver Toxicity Dan Xu, Manhong Wu, Sachiko Nishimura, Journal of Pharmacology and Experimental Therapeutics	2014	45

Page 1